Danaher Shares Plunge Most in Over 20 Years Despite Earnings Beat
Danaher reported better-than-expected Q2 earnings, but its core revenue guidance fell short of estimates, triggering a selloff that wiped out over 14% of the stock's value—the worst single-day decline in more than 20 years.
Key Numbers
Danaher Corporation (NYSE: DHR) posted second-quarter earnings that topped analyst expectations, but the company's core revenue guidance for the full year disappointed investors, sending shares tumbling more than 14% in the worst single-day selloff in over two decades.
Key Financial Results
| Metric | Value | vs. Expectations |
|---|---|---|
| Revenue | $7.8 billion | Beat |
| EPS | $2.50 | Beat |
| Core Revenue Growth | 3% | Missed |
Highlights from the Report
The company noted strong demand in life sciences and diagnostics but warned of a slowdown in certain end markets. Danaher also announced an internal restructuring to improve efficiency.
Guidance
Danaher forecasted full-year core revenue growth of 4% to 5%, below the 6% consensus estimate. It also lowered its Q3 core revenue outlook.
Impact on the Stock
DHR shares plunged 14.5% on the day, hitting multi-month lows. Trading volume was more than double the daily average.
What This Means for Investors
While quarterly results were solid, the weak guidance overshadowed the beat, signaling potential headwinds in demand. Investors should monitor demand trends in the coming quarters.
Frequently Asked Questions
Found this useful? Share it